The American Thoracic Society (ATS) 2019 Scientific Summaries
On May 17-22, the American Thoracic Society (ATS) will host its 115th International Conference in Dallas, Texas, bringing together the world’s leading pulmonary, critical care, and sleep professionals to share cutting-edge research in the fields of allergy/immunology, behavioral science, cardiology, environmental and occupational health, infectious disease and pulmonology.
This scientific summaries education center will present the latest breaking research from ATS 2019.
.jpg)
Dupilumab Reduces Severe Exacerbations In Patients With Acute Asthma
May 15, 2019
Patients with moderate-to-severe asthma who received dupilumab every 2 weeks had reduced acute severe exacerbations and improved lung function regardless of their bronchodilator reversibility status...
.jpg "Top 10 Stories from ATS 2019")
Top 10 Stories from ATS 2019
May 23, 2019This week, the American Thoracic Society hosted it’s 119th International Conference. Research spanned from novel treatment updates to public health warnings...
.jpg "Primary Care Visits Reduce Hospital Visits, Critical Care")
Primary Care Visits Reduce Hospital Visits, Critical Care
May 22, 2019Visiting the primary care doctor regularly appeared to reduce the rate of all-cause use of critical care...
.jpg "Homes of Current, Former Smokers Could Be Site of Bacterial Growth, Biofilm Formation")
Homes of Current, Former Smokers Could Be Site of Bacterial Growth, Biofilm Formation
May 22, 2019Particulate matter collected in the homes of current and former smokers indicate the houses of these individuals are a potential environment for bacterial growth and biofilm formation...
.jpg "RCT Results of Smoking Cessation Using a Smartphone App: A Q&A with Kenichiro Nishii")
RCT Results of Smoking Cessation Using a Smartphone App: A Q&A with Kenichiro Nishii
May 22, 2019Smoking cessation smartphone apps have the potential to help adults who want to quit smoking. However, to date, there have been few studies examining the efficacy of this treatment resource...
.jpg "Treatment With Budesonide/Formoterol Reduces Severe Exacerbations In Mild Asthma Patients Regardless Of Prior Treatment")
Treatment With Budesonide/Formoterol Reduces Severe Exacerbations In Mild Asthma Patients Regardless Of Prior Treatment
May 21, 2019Patients with mild asthma who received budesonide/formoterol (BUD/FORM) or BUD 200µg twice daily with as-needed terbutaline had reduced rates of exacerbation regardless of prior treatment...
